Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma

Clinical trial NCT00306618 · COMPLETED

Trial details

NCT number: NCT00306618
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Multiforme

Start date: 2006-01-01
Primary completion: 2007-11-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.